Minnesota HF1807 requires coverage of nonopioid drugs for pain treatment and management.
Minnesota HF1807 amends state statutes to require coverage of nonopioid drugs for pain treatment and management. The commissioner must adopt and implement a preferred drug list, ensuring nonopioid drugs are not disadvantaged compared to opioids. The commissioner must also consider the impact of any proposed deletions or modifications on public health and health disparities. The commissioner must provide public notice and conduct a public hearing before making any changes to the drug list.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.